In Vitro Kinetic Studies of Formation of Antigenic Advanced Glycation End Products (AGEs)
Open Access
- 1 February 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (9) , 5430-5437
- https://doi.org/10.1074/jbc.272.9.5430
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Thiamine Pyrophosphate and Pyridoxamine Inhibit the Formation of Antigenic Advanced Glycation End-Products: Comparison with AminoguanidineBiochemical and Biophysical Research Communications, 1996
- N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue ProteinsBiochemistry, 1995
- Are advanced glycation end-products associated with amyloidosis in Alzheimer’s disease?NeuroReport, 1995
- Radical AGEing in Alzheimer's diseaseTrends in Neurosciences, 1995
- Mechanism of Inhibition of Advanced Glycosylation by Aminoguanidine in VitroJournal of Carbohydrate Chemistry, 1993
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- Cross-linking and fluorescence changes of collagen by glycation and oxidationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- Production and characterization of antibodies to advanced glycation products on proteinsBiochemical and Biophysical Research Communications, 1989
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylationLife Sciences, 1988